Advertisement
Home Tags COPD

Tag: COPD

A "Western" diet appears to be associated with chronic obstructive pulmonary disease

‘Western’ Diet Associated With Respiratory Symptoms, COPD

0
Western dietary pattern associated with higher prevalence of wheeze, cough, phlegm
Chronic obstructive pulmonary disease prevalence

COPD Hospitalizations, Deaths, Prevalence Higher in Rural Areas

0
Higher for those living in rural areas than those in micropolitan or metropolitan areas
Long-term

Long-Term Inhaled Corticosteroid Use May Raise Fracture Risk

0
Long-term inhaled corticosteroid use for COPD tied to small increased risk of hip, upper extremity fracture
A home-based health coaching intervention can increase physical activity levels among patients with chronic obstructive pulmonary disease

Home Physical Activity Coaching May Up Physical Activity in COPD

0
More patients in coaching group were persistently active than those receiving usual care
For patients with chronic obstructive pulmonary disease

CVD Risk Up With β2-Agonist, Antimuscarinic Antagonist Start

0
New use of long-acting β2-agonists, antimuscarinic antagonists tied to higher CVD risk in first 30 days
New evidence regarding safety is spurring the U.S. Food and Drug Administration to remove a Boxed Warning from certain inhaled medications used to treat asthma and chronic obstructive pulmonary disease.

FDA Removes Boxed Warning From Certain Asthma Medications

0
Decision applies to long-acting beta agonists used in combination with inhaled corticosteroids
Individuals with rheumatoid arthritis have an increased risk of incident chronic obstructive pulmonary disease hospitalization compared with those in the general population

RA Associated With Higher Risk of COPD Hospitalization

0
Risk is 47 percent higher in RA patients than general population after adjustment for confounders
Treatment with long-acting muscarinic antagonists plus long-acting β-agonists is associated with fewer exacerbation events in patients with chronic obstructive pulmonary disease

LAMA Plus LABA Tied to Fewer Exacerbations in Stable COPD

0
Also might result in greater improvement in FEV1 than LABA plus corticosteroids
Patients with chronic obstructive pulmonary disease with an eosinophilic phenotype may benefit from mepolizumab

Mepolizumab Beneficial in COPD With Eosinophilic Phenotype

0
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab
Statin use is associated with a reduced risk of all-cause and pulmonary-related mortality in patients with chronic obstructive pulmonary disease

Statins Tied to Reduced Mortality Risk in COPD

0
Statin exposure associated with lower all-cause, pulmonary mortality